Purchasing Hep C Drugs at 340B pricing for inmates receiving Hepatitis treatment from VCU providers…

The Virginia Department of Corrections awarded contract PO05066137-V3 to VCU Health System on July 16, 2026, for the procurement of Hepatitis C medications at 340B pricing program rates. The contract covers pharmaceutical supply for inmates receiving Hepatitis C treatment administered by VCU Health System providers. The period of performance encompasses the fiscal year from July 1, 2025, through June 30, 2026, with invoices submitted during this twelve-month window. The cumulative contract value totals $3,471,791.31.

The deliverables are structured as a single line item representing a complete lot of Hepatitis C pharmaceutical products procured under the 340B Drug Pricing Program, a federal program that requires manufacturers to provide outpatient drugs at reduced prices to eligible healthcare entities. Products are to be delivered to Zabiullah Moqim as the designated recipient. As the prime contractor, VCU Health System assumes responsibility for sourcing and delivering the requisite pharmaceutical inventory to support the Department of Corrections' inmate healthcare obligations throughout the specified contract term.